论文部分内容阅读
目的探讨参松养心胶囊与胺碘酮联合治疗心律失常的临床效果。方法 60例心律失常患者作为研究对象,根据患者意愿分为对照组和观察组,每组30例。观察组接受参松养心胶囊和胺碘酮治疗,对照组仅接受胺碘酮治疗,比较两组治疗效果及不良反应。结果观察组和对照组总有效率分别为90.0%和66.7%,组间差异具有统计学意义(P<0.05);观察组和对照组不良反应发生率分别为10.0%和16.7%,组间差异无统计学意义(P>0.05)。结论参松养心胶囊与胺碘酮联合用药可提升心律失常控制效果,值得推广使用。
Objective To investigate the clinical effect of Shensong Yangxin Capsule combined with amiodarone in the treatment of arrhythmia. Methods Sixty patients with arrhythmia were divided into control group and observation group according to patients’ wishes, 30 cases in each group. The observation group received Shensong Yangxin Capsule and amiodarone, while the control group received amiodarone alone. The treatment effects and adverse reactions were compared between the two groups. Results The total effective rates in the observation group and the control group were 90.0% and 66.7%, respectively, with significant differences between the two groups (P <0.05). Adverse reactions in the observation and control groups were 10.0% and 16.7% respectively. No statistical significance (P> 0.05). Conclusion Shensongyangxin capsules combined with amiodarone can improve arrhythmia control effect, it is worth to promote the use of.